The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke—Between Benefit and Risk: A Systematic Review
Ischemic stroke is a disease related to abnormal blood flow that leads to brain dysfunction. The early and late phases of the disease are distinguished. A distinction is made between the early and late stages of the disease, and the best effect in treating an ischemic stroke is usually achieved with...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-01-01
|
| Series: | International Journal of Molecular Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1422-0067/23/3/1043 |
| _version_ | 1797487625243721728 |
|---|---|
| author | Joanna Sikora Aleksandra Karczmarska-Wódzka Joanna Bugieda Przemysław Sobczak |
| author_facet | Joanna Sikora Aleksandra Karczmarska-Wódzka Joanna Bugieda Przemysław Sobczak |
| author_sort | Joanna Sikora |
| collection | DOAJ |
| description | Ischemic stroke is a disease related to abnormal blood flow that leads to brain dysfunction. The early and late phases of the disease are distinguished. A distinction is made between the early and late stages of the disease, and the best effect in treating an ischemic stroke is usually achieved within the first hours after the onset of symptoms. This review looked at studies platelet activity monitoring studies to determine the risks and benefits of various approaches including antiplatelet therapy. A study was conducted on recently published literature based on PRISMA. This review includes 32 research articles directly addressing the importance of monitoring platelet function during antiplatelet therapy (dual or monotherapy) after ischemic stroke. In patients with transient ischemic attack or ischemic stroke, antiplatelet therapy can reduce the risk of stroke by 11–15%, assuming that patients respond well. Secondary prevention results are dependent on platelet reactivity, meaning that patients do not respond equally to antiplatelet therapy. It is very important that aspirin-resistant patients can benefit from the use of dual antiplatelet therapy. The individualized approach to secondary stroke prevention is to administer the most appropriate drug at the correct dose and apply the optimal therapeutic procedure to the individual patient. |
| first_indexed | 2024-03-09T23:50:25Z |
| format | Article |
| id | doaj.art-2f06dc6aa0684f73ac017cde13223803 |
| institution | Directory Open Access Journal |
| issn | 1661-6596 1422-0067 |
| language | English |
| last_indexed | 2024-03-09T23:50:25Z |
| publishDate | 2022-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | International Journal of Molecular Sciences |
| spelling | doaj.art-2f06dc6aa0684f73ac017cde132238032023-11-23T16:34:01ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-01-01233104310.3390/ijms23031043The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke—Between Benefit and Risk: A Systematic ReviewJoanna Sikora0Aleksandra Karczmarska-Wódzka1Joanna Bugieda2Przemysław Sobczak3Research and Education Unit for Experimental Biotechnology, Department of Transplantology and General Surgery, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, PolandResearch and Education Unit for Experimental Biotechnology, Department of Transplantology and General Surgery, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, PolandResearch and Education Unit for Experimental Biotechnology, Department of Transplantology and General Surgery, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, PolandDepartment of Laboratory Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, PolandIschemic stroke is a disease related to abnormal blood flow that leads to brain dysfunction. The early and late phases of the disease are distinguished. A distinction is made between the early and late stages of the disease, and the best effect in treating an ischemic stroke is usually achieved within the first hours after the onset of symptoms. This review looked at studies platelet activity monitoring studies to determine the risks and benefits of various approaches including antiplatelet therapy. A study was conducted on recently published literature based on PRISMA. This review includes 32 research articles directly addressing the importance of monitoring platelet function during antiplatelet therapy (dual or monotherapy) after ischemic stroke. In patients with transient ischemic attack or ischemic stroke, antiplatelet therapy can reduce the risk of stroke by 11–15%, assuming that patients respond well. Secondary prevention results are dependent on platelet reactivity, meaning that patients do not respond equally to antiplatelet therapy. It is very important that aspirin-resistant patients can benefit from the use of dual antiplatelet therapy. The individualized approach to secondary stroke prevention is to administer the most appropriate drug at the correct dose and apply the optimal therapeutic procedure to the individual patient.https://www.mdpi.com/1422-0067/23/3/1043antiplatelet drugsischemic strokemonitoring of platelet functionpersonalized treatment |
| spellingShingle | Joanna Sikora Aleksandra Karczmarska-Wódzka Joanna Bugieda Przemysław Sobczak The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke—Between Benefit and Risk: A Systematic Review International Journal of Molecular Sciences antiplatelet drugs ischemic stroke monitoring of platelet function personalized treatment |
| title | The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke—Between Benefit and Risk: A Systematic Review |
| title_full | The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke—Between Benefit and Risk: A Systematic Review |
| title_fullStr | The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke—Between Benefit and Risk: A Systematic Review |
| title_full_unstemmed | The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke—Between Benefit and Risk: A Systematic Review |
| title_short | The Importance of Platelets Response during Antiplatelet Treatment after Ischemic Stroke—Between Benefit and Risk: A Systematic Review |
| title_sort | importance of platelets response during antiplatelet treatment after ischemic stroke between benefit and risk a systematic review |
| topic | antiplatelet drugs ischemic stroke monitoring of platelet function personalized treatment |
| url | https://www.mdpi.com/1422-0067/23/3/1043 |
| work_keys_str_mv | AT joannasikora theimportanceofplateletsresponseduringantiplatelettreatmentafterischemicstrokebetweenbenefitandriskasystematicreview AT aleksandrakarczmarskawodzka theimportanceofplateletsresponseduringantiplatelettreatmentafterischemicstrokebetweenbenefitandriskasystematicreview AT joannabugieda theimportanceofplateletsresponseduringantiplatelettreatmentafterischemicstrokebetweenbenefitandriskasystematicreview AT przemysławsobczak theimportanceofplateletsresponseduringantiplatelettreatmentafterischemicstrokebetweenbenefitandriskasystematicreview AT joannasikora importanceofplateletsresponseduringantiplatelettreatmentafterischemicstrokebetweenbenefitandriskasystematicreview AT aleksandrakarczmarskawodzka importanceofplateletsresponseduringantiplatelettreatmentafterischemicstrokebetweenbenefitandriskasystematicreview AT joannabugieda importanceofplateletsresponseduringantiplatelettreatmentafterischemicstrokebetweenbenefitandriskasystematicreview AT przemysławsobczak importanceofplateletsresponseduringantiplatelettreatmentafterischemicstrokebetweenbenefitandriskasystematicreview |